Try our beta test site
7 studies found for:    Cellceutix Pharmaceuticals
Show Display Options
Rank Status Study
1 Completed Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers
Condition: Psoriasis
Interventions: Drug: Prurisol;   Drug: Ziagen
2 Recruiting Phase 2 Study to Evaluate the Safety & Efficacy of Brilacidin Oral Rinse in Patients With Head and Neck Cancer
Conditions: Head and Neck Neoplasms;   Mucositis;   Stomatitis;   Mouth Diseases
Interventions: Drug: Brilacidin;   Other: Placebo
3 Completed Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
Conditions: Skin Infection;   Bacterial Infection
Interventions: Drug: Daptomycin;   Drug: Brilacidin
4 Recruiting A Phase 2 Study of Kevetrin in Subjects With Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Kevetrin
5 Completed Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: Prurisol;   Drug: Placebo
6 Recruiting Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
Condition: Chronic Stable Plaque Psoriasis
Interventions: Drug: Placebo;   Drug: 400 mg (200 mg BID);   Drug: 300 mg (150 mg BID)
7 Completed A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors
Condition: Solid Tumors
Intervention: Drug: thioureidobutyronitrile

Study has passed its completion date and status has not been verified in more than two years.